Diabetes clinical research is conducted at institutions, research labs, and universities all around the world. Because Diabetes is such a complex disease, most organizations will choose either Type 1 or Type 2 to devote its research. One particular organization, the Diabetes Clinical Research Program at Benaroya Research Institute focuses on Type 1 Diabetes research. They maintain TrialNet, which is a Diabetes network consisting of eighteen clinical sites located around the world and their goal is to ease the burden of families who have a child diagnosed with Diabetes.
They achieve this objective through disease prevention, early detection and screening, and new therapies.After a child is admitted to the program, they also screen the patient’s family members as well. They have tested over 200,000 family members. Since prevention and early detection are important, they hope to minimize some issues for the family by detecting the risk and dealing with it head on.
Diabetes Research and Clinical Practice
Diabetes Research and Clinical Practice, the official journal of the International Diabetes Federation, is an international journal for medical professionals, clinical researchers, and health care workers. The journal contains articles and reviews on Diabetes, clinical research and trials, patient care, and other topics related to Diabetes. They submit cutting-edge information regarding Scientific, Technical, and Medical Information providing an exchange of knowledge between thinkers and experts. Some topics include genetics, immunology, and epidemiology. The journal is published by Elsevier, which is renowned for receiving countless awards and honors. The Diabetes research and clinical practice journal can be read online at elsevier.com.
Diabetes Research and Clinical Practice Impact Factor
Diabetes research and clinical practice impact facto rare usually connected during the publishing phase. When the results of clinical research are assessed and then published into papers and journals, the publications are given a ranking. This ranking is called the Journal Impact Factor.It evolved from the Journal Citation Report, which is a product of Thomson Institute for Scientific Information. They provide quantitative tools for evaluating various journals.
The impact factor is how often an article in a journal has been cited in a given period. The impact factor for a journal is calculated based on a three-year period, and can be considered the average number of times published papers are cited up to two years after publication. For example, the number of times an articlepublished in 2010-2011 was cited in indexed journals during 2012and divide it by the number of articles, reviews, proceedings or notes published in 2010-2011 and the number received is the impact factor. The impact factor for Diabetes Research and Clinical Practiceis 2.134 for the current year and 2.231 for the five-year impact factor.